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investigated (except for kidney) was observed. However, the 
QUANTEC constraints for all plans and OARs were satisfied.  
Conclusions: The results of this study seem to demonstrate 
that it is possible to safely perform a dose escalation 
ensuring ICRU PTV indication criteria coverage and satisfying 
all QUANTEC constraints. 
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Purpose/Objective: Recent EORTC studies report an increase 
in survival in breast cancer patients treated with RT when 
the internal mammary node (IMN) is included. The 
aforementioned studies were based on conventional 3D 
irradiation with photons in breast and supraclavicular and 
axillary nodes and a direct electron field in the IMN. To our 
knowledge, the safety of including IMN in IMRT has not been 
studied to date. The objective of the study was to 
retrospectively evaluate the dosimetric impact on the usual 
organs at risk (OAR) in the irradiation of the left breast/chest 
wall (heart, lungs, and contralateral breast) treated with 
IMRT. 
Materials and Methods: We selected all breast patients (n = 
30) treated with IMRT (left breast, left chest wall, 
with/without nodes and with/without boost) in 2014. CT 
planning was performed in all patients with a Philips Big Bore 
CT. We defined the volumes to irradiate and the OAR. We 
performed a new IMRT planning to compare with the previous 
technique. We used our standard distribution of fields in each 
case. Treatment planning and volume definition were defined 
using the Eclipse V8.9 planning system from Varian. After 
optimizing dosimetry to obtain the best coverage and 
homogeneous distribution of PTVs, we compared the dose 
received in OAR for each of the 2 plans, considering the 
constraints of our service (mainly based in QUANTEC), which 
are: 
-Heart: V30<30%; V25<15; Dmean<10Gy 
-Lung: V5<60%; V20<30% 
-Ipsilateral Lung: V20<30% 
-Contralateral Lung: V5<40% 
-Contralateral Breast: V5<2% (This is an orientation constraint 
because heart and lung area priority constraint). 
We recorded the values of these indexes for IMRT with and 
without IMN. 
Results: Table 1 shows the mean values recorded for IMRT 
with and without IMN, and the differences between the two 
plans. We found a slight increase in dose in OAR when IMN 
was included, but this increase did not exceed the limits 




Conclusions: IMN irradiation of the left breast can be safely 
performed with the new treatment techniques (IMRT) 
because it does not significantly increase the dose received 
by the OAR. 
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Purpose/Objective: The aim of this study was to compare 
the various dosimetric parameters of volumetric-modulated 
arc therapy (VMAT) for prostate cancer using a 160-leaf 
multileaf collimator (5mm-leaf, Agility) with VMAT using 80 
MLC (10mm-leaf, MLCi2). Monitor units and number of control 
points among those MLCs were also evaluated. 
Materials and Methods: Single-arc VMAT plans with Agility 
and MLCi2 were compared for 10 low to intermediate risk 
prostate cancer patients. Clinical target volume included the 
prostate and the proximal seminal vesicles. The planning 
target volume (PTV) was defined as CTV with a margin of 
5mm posterior and 8mm in other directions. The mean dose 
to PTV was 76 Gy delivered in 38 fractions. Rectums were 
contoured as solid organs from anal verge to sigmoid flexure. 
The dosimetric parameters of VMAT plans with Agility and 
MLCi2 were calculated in a Monaco treatment planning 
system for Elekta Synergy linac with Monte Carlo algorithm. 
The parameters for PTV were the near minimum dose (D98), 
the near maximum dose (D2), heterogeneity Index (HI) and 
conformity Index (CI). The parameters for rectum were V70, 
V60, V50 and V40. Monitor units and control points were also 
evaluated. Statistical analysis to evaluate the differences two 
categories was performed by the paired, two-tailed Student's 
t-test. 
Results:The mean PTV was 110.8 cc (range 70.0 to 229.4 cc). 
The mean volume of rectum was 41.9 cc (range 26.6 to 57.1 
cc). The average of the near minimum dose of PTVs (D98) 
were 71.9 Gy in Agility and 71.6 Gy in MLCi2 (P=0.02). The 
average of the near maximum dose of PTVs (D2), HI and CI 
were similar results among those MLCs. For rectum, the 
average of V70, V60, V50 and V40 in Agility were 8.56 %, 18.7 
%, 27.7% and 37.8%, respectively. The average of those 
parameters in MLCi2 were 8.72 %, 19.8 %, 29.9 % and 41.3 %, 
respectively. The average of V60, 50 and 40 in Agility was 
significantly better than those in MLCi2 (P=0.005-0.014). The 
average MUs were 452.8 in Agility and 416.9 in MLCi2, 
respectively, which showed significantly differences 
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(P=0.019). The average control points in Agility and MLCi2 
were 98.6 and 99.9, respectively, with no significant 
differences. 
Conclusions: Agility allowed statistically significant 
improvements in both PTV coverages and rectum dose sparing 
compared with MLCi2. Although Agility showed statistically 
higher outputs probably because of smaller segments, this 
may not be an important issue in the clinical setting.  
   
 
Poster: RTT track: Image guided radiotherapy, adaptive 
radiotherapy, geometric uncertainties and margins  
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Purpose/Objective: There is limited information available on 
the optimal Planning Target Volume (PTV) expansions and 
image guidance methods for post-prostatectomy intensity 
modulated radiotherapy (PP-IMRT). Large uniform PTV 
margins aligned to bony anatomy are frequently used but 
irradiate a large volume of normal tissue. The aim of this 
study is to assess the impact of various PTV margin recipes 
with and without soft tissue matching. 
Materials and Methods: The Cone Beam CT (CBCT) images 
(n=377) of 40 patients who received PP-IMRT with daily online 
alignment to bony anatomy (BA) were reviewed. Six different 
PTV expansions were assessed (see Table 1). Each PTV was 
assessed for size, bladder and rectum coverage and 
geographic miss with and without an averaged soft tissue 
(AST) match. 
Results: The 0.5cm uniform expansion (median = 222.3cc) 
was the smallest and 1cm uniform (361.7cc) the largest. 
Table 1 outlines the percentage of rectum and bladder within 
the PTV as well as rates of geographic miss with and without 
AST matching. AST matching reduced the rate of geographic 
miss by half to two thirds depending on the PTV expansion. 
The AST matching technique reduces geographic miss rates to 
<10% for all PTV expansions. When using the smaller 
anisotropic PTV expansion, the geographic miss rate of 21.0% 
with BA matching would be reduced to 5.6% with AST 
matching. 
Table 1: Results for each PTV 
 
 
Conclusions: The optimal image guidance policy for PP-IMRT 
is daily AST matching using CBCT scans with a small 
anisotropic PTV expansion. Caution must be taken during 
online matching to ensure adequate training of the Radiation 
Therapists performing this procedure.  
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Purpose/Objective: In a context of prostate cancer 
treatment, we introduced daily kV imaging since five years. 
IGRT feed back loop clearly demonstrated that PTV margins 
currently used are consistent with daily bone registration but 
can not be reduced without changing our practice. IGRT 
based on radio opaque markers registration is a compulsory 
step before reducing PTV margin and dose escalation. The 
choice of optimal fiducial markers is important because 
artifact and poor localization should have consequences on 
accuracy of treatment. 
Materials and Methods: We compared different radio-opaque 
markers : PolyMark (1,0mm diameter, 3mm long, - polymer 
marker Civco), Soft tissue gold marker (1,2mm diameter, 
3mm long - gold marker Civco), Flexicoil (0,9 mm 
diameter,10 mm long - gold marker Civco) and Gold Anchor, 
(0,5 mm diameter, 10 mm long - gold marker Gold Anchor). 
 
 
Characteristics such as contrast noise ratio, partial volume 
effect, artifact have been studied on different imaging 
modalities (CT, MRI, MV and kV). Then treatment has been 
simulated on anthropomorphic phantom and inter-operator 
variability of fiducial markers registration versus bone 
registration has been analyzed. 
Results: Radio-opaque registration would significantly reduce 
margins while ensuring good coverage of PTV. Neverteheless 
markers show differents characteristics for imaging as below: 
CNR CT imaging 
